Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWind and bloating are among the most commonly reported digestive side effects of Mounjaro. The medicine slows how quickly food moves through your stomach, and that change in gut motility can cause excess gas, bloating, and burping, particularly in the first few weeks of treatment or after a dose increase. For most people it eases as the body adjusts. This page explains the mechanism, what the evidence says, and the practical steps that tend to help — because for a prescription medicine like Mounjaro (tirzepatide), which requires clinical assessment before a prescriber can approve it, understanding what to expect is half the battle.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's Wednesday evening. You injected this morning, followed every instruction, and now you're sitting on the sofa feeling distinctly gassy and uncomfortable. You're not imagining it, and you haven't done anything wrong. Wind on Mounjaro is real, common, and has a straightforward physiological explanation.
Tirzepatide is a dual GIP and GLP-1 receptor agonist, the only medicine of its type licensed for weight management in the UK. One of the ways it works is by slowing gastric emptying: food lingers longer in the stomach, which keeps you full for longer. That slower transit time also gives gut bacteria more time to ferment undigested food, producing gas as a by-product. The result is what many people describe as trapped wind, persistent bloating, or frequent burping, especially after meals.
The NHS tirzepatide patient information page lists burping, nausea, and abdominal discomfort among the recognised side effects. These effects are part of the same mechanism that makes the medicine effective, they're not a sign something has gone wrong. Most people find the symptoms are at their worst in the first two weeks after starting or stepping up to a new dose, then gradually settle as the gut adapts to the changed motility pattern. Understanding that timing can make the early weeks feel a lot more manageable.
If you want to understand the broader picture of how tirzepatide works, the Mounjaro explained overview covers the dual-agonist mechanism in more detail.
Because the root cause is slowed gastric emptying, anything that adds more gas-producing pressure to an already-slower system is going to compound the problem. Large meals are probably the biggest culprit. Where you might previously have eaten a full plate in fifteen minutes and felt fine, that same portion on Mounjaro can sit heavily and ferment more completely before it moves on. Patients often tell our prescribers that switching to three smaller meals, or even four or five light ones spread across the day, makes a noticeable difference within a few days.
Carbonated drinks add gas directly. High-fat foods slow gastric emptying even further on top of Mounjaro's existing effect, a double hit. Foods known to be high in fermentable carbohydrates (onions, garlic, beans, cruciferous vegetables) can worsen symptoms in some people, though they don't need to be cut out permanently; reducing them temporarily while your body settles is often enough.
Eating slowly and chewing thoroughly gives digestion a head start. Walking after meals (even a short one) supports gut motility gently without requiring any significant effort. Some people find peppermint tea helpful for relieving bloating; there's reasonable evidence for its mild antispasmodic effect on the gut, though it won't address the underlying cause.
Specific questions about whether wind pain is part of what you're experiencing are answered on the Mounjaro wind pain page, which looks at when discomfort crosses into something worth discussing with a prescriber.
Ordinary gas on Mounjaro is uncomfortable, sometimes embarrassing, but not dangerous. The pattern to watch for is a change in the character of the symptom: if bloating becomes severe, if you develop persistent pain in your upper abdomen that radiates to the back, or if you have vomiting alongside significant stomach pain, those symptoms need prompt medical assessment.
In January 2026 the MHRA issued a Drug Safety Update flagging acute pancreatitis as an infrequent but serious side effect of GLP-1 medicines, including tirzepatide. Pancreatitis typically presents as severe, constant upper abdominal pain, often reaching through to the back, quite different in quality from the gassiness and bloating most people experience. If that kind of pain develops, stop taking the medicine and seek medical help the same day. The bad wind on Mounjaro page goes further on distinguishing ordinary digestive discomfort from symptoms that need attention.
For most people reading this, though, what they're dealing with is plain old wind: noisy, uncomfortable, occasionally socially awkward, and likely to improve in the coming weeks. The trapped wind on Mounjaro page covers the specific scenario where gas seems to be stuck rather than passing, and what helps in that situation.
For a small number of people, gastrointestinal symptoms on Mounjaro are severe enough to affect daily life beyond the first couple of weeks. That's worth raising with whoever is overseeing your treatment, because the prescriber has options: slowing down the titration schedule, holding a dose for longer before stepping up, or reviewing whether any other factors are contributing.
If you're considering Mounjaro for the first time and the prospect of digestive side effects is part of what's giving you pause, it's worth knowing that the tirzepatide clinical trial programme (which enrolled thousands of adults) showed the majority of GI effects were mild to moderate and time-limited. The evidence on both results and tolerability is summarised on the tirzepatide overview page.
Cost is sometimes a factor in whether people stay on treatment through the difficult early weeks rather than stopping prematurely. The Mounjaro cost context page explains what legitimate private treatment typically includes and what to look for in any provider. And if you're wondering whether Mounjaro is the right option for your situation, the weight-loss treatments overview sets out what's licensed in the UK and how they compare.
If you'd like a prescriber to review whether Mounjaro is clinically suitable for you, you can check your eligibility with a free consultation at any time, a real clinician reads your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.